Claret Asset Management’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$205K Sell
3,400
-5,854
-63% -$273K 0.02% 490
2026
Q1
$334K Buy
9,254
+1
+0% +$42 0.04% 164
2025
Q4
$436K Sell
9,253
-3,913
-30% -$165K 0.05% 122
2025
Q3
$428K Sell
13,166
-77
-0.6% -$2.74K 0.05% 118
2025
Q2
$546K Buy
13,243
+2,522
+24% +$97.4K 0.07% 103
2025
Q1
$448K Buy
+10,721
New +$558K 0.06% 114
2024
Q4
Sell
-3,020
Closed -$209K 310
2024
Q3
$209K Buy
+3,020
New +$195K 0.03% 296

Other funds holding BRKR

Claret Asset Management's BRKR Position: Q2 2026 in Review

Claret Asset Management reduced its Bruker (BRKR) stake by 63% in Q2 2026, selling an estimated $273K and leaving 3,400 shares worth $205K. The position accounts for 0.02% of the portfolio, ranked #490.

Claret Asset Management first reported a position in BRKR in Q3 2024 and has held it in 7 quarters since. The position peaked at $546K in Q2 2025. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Claret Asset Management held 3,400 shares of Bruker worth $205K as of Q2 2026.
  • Claret Asset Management sold 5,854 Bruker shares in Q2 2026, an estimated $273K.
  • Bruker made up 0.02% of Claret Asset Management's portfolio in Q2 2026, its #490 holding.
  • Claret Asset Management first reported a position in Bruker in Q3 2024 and has held it in 7 quarters since.
  • Claret Asset Management's Bruker position peaked at $546K in Q2 2025.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.